Tech Company Financing Transactions
Grow Therapy Funding Round
Grow Therapy closed a $150 million Series D venture capital round on 3/3/2026. Backers included Goldman Sachs, TCV and BCI.
Transaction Overview
Company Name
Announced On
3/3/2026
Transaction Type
Venture Equity
Amount
$150,000,000
Round
Series D
Investors
Goldman Sachs (Lead Investor)
TCV (Lead Investor) (Gautam Gupta)
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
141 West 24 St.
New York, NY 10011
USA
New York, NY 10011
USA
Phone
Undisclosed
Website
Email Address
Overview
We believe therapy is an essential part of becoming the best versions of ourselves. No matter who you are or where you are starting, it's more than support through challenge -- it's the foundation to grow, heal and lead lives that are more resilient, empathic, hopeful and powerful.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jake Cooper
Browse more venture capital transactions:
Prev: 3/3/2026: Escargot venture capital transaction
Next: 3/3/2026: Burst venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records on this site are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs